Nuala Moran

The finalists of ACES 2013 are proof that Europe has the ingredients to create the best of high tech start-ups, while their founders are inspiring entrepreneur role models. But more support is needed to help others learn from – and build on – these exemplars

There are fine lines to tread – and regulatory, technical and cultural obstacles to negotiate – to protect the IP rights that underpin commercialisation and defend individual privacy when opening up and interconnecting Big Data stores

Models that demonstrate how Big Data can create jobs, foster resilience and make healthcare systems sustainable exist today. Now leadership is needed to build on this and stimulate a new wave of economic and social progress

The amazing thing about Big Data is not the sheer volume, but what we can do with it. This makes it imperative to get Europe’s new data protection rules right – and as soon as possible – says Neelie Kroes, Commissioner for the Digital Agenda

Negotiations over IP are acknowledged as one of the biggest bottlenecks in university/industry collaborations. A number of piecemeal schemes aim to overcome this, but a systematic approach is required to create more liquid markets for research outputs

Third generation cognitive computing is making sense of data mountains and starting to deliver remarkable improvements in healthcare. Now, sensitively calibrated data protection rules are needed – to reassure patients and protect privacy, whilst allowing progress to continue

As the number one priority for ICT research, the 10-year FET Flagship projects in graphene and computer modelling of the brain announced this week are guaranteed €1B each - regardless of any cuts in the proposed €80B Horizon 2020 programme

Six of the world’s most prestigious public drug discovery organisations are joining forces in a bid to improve the conversion rate of basic research into much-needed new therapies

It’s up to MEPs to ally with the Commission and stop the European Council cutting the proposed €80B research programme, Máire Geoghegan-Quinn, R&D Commissioner, tells the European Parliament as negotiations reach a head

Following a positive ruling on patents and a decision to maintain funding for embryonic stem cell research in Horizon 2020, things are looking up for regenerative medicine. Now further support is needed to deliver on the therapeutic potential, experts say in a Science|Business Webinar